Fatma Seher Pehlivan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Fatma Seher Pehlivan has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Ömer Atmış
Department of Pathology, Faculty of Medicine, Manisa Celal Bayar University, Manisa, Turkey
11 shared publications - Hanife Seda Mavili
Department of Pathology, Faculty of Medicine, Manisa Celal Bayar University, Manisa, Turkey
10 shared publications - Semin Ayhan
Department of Pathology, Faculty of Medicine, Manisa Celal Bayar University, Manisa, Turkey
7 shared publications - Ayça Tan
Manisa Celal Bayar University Faculty of Medicine, Department of Pathology, Manisa, Türkiye
5 shared publications - Ahmet Burak Ağaoğlu
Department of Medical Oncology, Manisa Celal Bayar University, Manisa 45030, Turkey
2 shared publications - Ali̇ Riza Kandi̇lOğlu
MANİSA CELÂL BAYAR ÜNİVERSİTESİ, TIP FAKÜLTESİ
2 shared publications
Latest Publications
- Open Access
- 10 November 2026
- Published by Uludag Universitesi Tip Fakultesi Dergisi in Uludağ Üniversitesi Tıp Fakültesi Dergisi
- Vol. 52
Single Umbilical Artery in Fetal Autopsies: An Isolated Variant or a Marker of Multisystem Congenital Pathology?
Single umbilical artery (SUA) is one of the most common umbilical cord anomalies encountered during the prenatal and perinatal periods. Although isolated cases may follow a benign course, the presence of SUA has been reported to be associated with various structural congenital anomalies. The aim of this study was to determine the prevalence of SUA in a 10-year fetal autopsy cohort, to evaluate the association between the presence of SUA and congenital anomalies, and to demonstrate the risk it carries with regard to multisystem organ anomalies. A total of 641 fetal autopsies performed were retrospectively reviewed. Maternal age, gestational week, abortion/induction status, presence of SUA, and central nervous system, genitourinary system, gastrointestinal system, cardiac, pulmonary, musculoskeletal system, and multiple anomalies were recorded. Cases were classified according to umbilical cord structure into two groups: those with a single umbilical artery and those with a normal two-umbilical-artery configuration. SUA was detected in 35 (5.5%) of the 641 fetal autopsy cases. The rate of any congenital anomaly in cases with SUA was significantly higher than in cases with normal umbilical cord structure (p=0.0003). Multisystem congenital anomalies were observed significantly more frequently in the SUA group (p<0.0001). The presence of a single umbilical artery is associated with an increased risk of congenital anomalies in the fetal autopsy cohort and constitutes an important finding that warrants close attention. When SUA is detected prenatally, it should not be regarded solely as an umbilical cord anomaly; a detailed systemic examination should be performed for accompanying structural anomalies.
- 10 November 2026
- Published by Uludag Universitesi Tip Fakultesi Dergisi in Uludağ Üniversitesi Tıp Fakültesi Dergisi
- Vol. 52
Open AccessSingle Umbilical Artery in Fetal Autopsies: An Isolated Variant or a Marker of Multisystem Congenital Pathology?
Single umbilical artery (SUA) is one of the most common umbilical cord anomalies encountered during the prenatal and perinatal periods. Although isolated cases may follow a benign course, the presence of SUA has been reported to be associated with various structural congenital anomalies. The aim of this study was to determine the prevalence of SUA in a 10-year fetal autopsy cohort, to evaluate the association between the presence of SUA and congenital anomalies, and to demonstrate the risk it carries with regard to multisystem organ anomalies. A total of 641 fetal autopsies performed were retrospectively reviewed. Maternal age, gestational week, abortion/induction status, presence of SUA, and central nervous system, genitourinary system, gastrointestinal system, cardiac, pulmonary, musculoskeletal system, and multiple anomalies were recorded. Cases were classified according to umbilical cord structure into two groups: those with a single umbilical artery and those with a normal two-umbilical-artery configuration. SUA was detected in 35 (5.5%) of the 641 fetal autopsy cases. The rate of any congenital anomaly in cases with SUA was significantly higher than in cases with normal umbilical cord structure (p=0.0003). Multisystem congenital anomalies were observed significantly more frequently in the SUA group (p<0.0001). The presence of a single umbilical artery is associated with an increased risk of congenital anomalies in the fetal autopsy cohort and constitutes an important finding that warrants close attention. When SUA is detected prenatally, it should not be regarded solely as an umbilical cord anomaly; a detailed systemic examination should be performed for accompanying structural anomalies.
- Open Access
- 13 October 2026
- Published by Termedia Sp. z.o.o. in Polish Journal of Pathology
Extramural venous invasion as an independent predictor of lymph node metastasis in colon adenocarcinoma: a multivariate analysis
Introduction: Lymph node metastasis (LNM) is a key determinant of prognosis and treatment decisions in colon adenocarcinoma. Among histopathological features associated with tumor aggressiveness, extramural venous invasion (EMVI) has been increasingly recognized as an adverse factor; however, its independent role in predicting nodal metastasis remains incompletely defined. Material and Methods: In this retrospective study, 180 consecutive patients who underwent primary surgical resection for colon adenocarcinoma, excluding rectal tumors, neoadjuvant-treated cases, and histological subtypes other than adenocarcinoma NOS, were evaluated. Histopathological parameters, including EMVI, intramural venous invasion, lymphovascular invasion (LVI), perineural invasion (PNI), tumor budding, and tumor deposits, were systematically reviewed, and elastic staining was used in equivocal cases. Associations with LNM were analyzed using univariate and multivariate logistic regression. Results: Lymph node metastasis was identified in 47.8% of patients, and EMVI was present in 21.7% and was significantly more frequent in patients with nodal metastasis. In multivariate analysis, LVI was the strongest independent predictor of LNM, followed by PNI, EMVI, and high tumor budding. The model demonstrated good calibration and an overall accuracy of 80%. Conclusions: Extramural venous invasion is an independent predictor of LNM and reflects a biologically aggressive tumor phenotype. Its routine assessment, together with other high-risk features, may improve risk stratification and support more informed clinical decision-making.
- 13 October 2026
- Published by Termedia Sp. z.o.o. in Polish Journal of Pathology
Open AccessExtramural venous invasion as an independent predictor of lymph node metastasis in colon adenocarcinoma: a multivariate analysis
Introduction: Lymph node metastasis (LNM) is a key determinant of prognosis and treatment decisions in colon adenocarcinoma. Among histopathological features associated with tumor aggressiveness, extramural venous invasion (EMVI) has been increasingly recognized as an adverse factor; however, its independent role in predicting nodal metastasis remains incompletely defined. Material and Methods: In this retrospective study, 180 consecutive patients who underwent primary surgical resection for colon adenocarcinoma, excluding rectal tumors, neoadjuvant-treated cases, and histological subtypes other than adenocarcinoma NOS, were evaluated. Histopathological parameters, including EMVI, intramural venous invasion, lymphovascular invasion (LVI), perineural invasion (PNI), tumor budding, and tumor deposits, were systematically reviewed, and elastic staining was used in equivocal cases. Associations with LNM were analyzed using univariate and multivariate logistic regression. Results: Lymph node metastasis was identified in 47.8% of patients, and EMVI was present in 21.7% and was significantly more frequent in patients with nodal metastasis. In multivariate analysis, LVI was the strongest independent predictor of LNM, followed by PNI, EMVI, and high tumor budding. The model demonstrated good calibration and an overall accuracy of 80%. Conclusions: Extramural venous invasion is an independent predictor of LNM and reflects a biologically aggressive tumor phenotype. Its routine assessment, together with other high-risk features, may improve risk stratification and support more informed clinical decision-making.
- 15 September 2026
- Published by Wolters Kluwer Health in Applied Immunohistochemistry & Molecular Morphology
- Vol. 34 (6) , 437-445
Autophagy- and Stress-Related Biomarkers in Pretreatment Rectal Adenocarcinoma Biopsies: Associations With Pathologic Response to Neoadjuvant Therapy and Survival
Neoadjuvant chemoradiotherapy (nCRT) is the standard treatment for locally advanced rectal adenocarcinoma, yet therapeutic response varies widely and reliable biomarkers are lacking. This study evaluated the immunohistochemical expression of Beclin-1, LC3A, HIF-1α, Bcl-2, and eIF2α in pretreatment biopsies and explored their association with tumor regression grade (TRG) and survival. A retrospective analysis was performed on 53 patients with rectal adenocarcinoma who underwent neoadjuvant therapy and surgical resection between 2010 and 2025. Immunohistochemical expression of 5 markers was evaluated semiquantitatively and correlated with TRG (both Modified Mandard and AJCC systems) and survival outcomes. Among the evaluated markers, only Beclin-1 expression correlated significantly with poorer histopathologic response in both TRG systems (Modified Mandard: ρ =0.35, P =0.010; AJCC: ρ =0.34, P =0.012). ROC analysis confirmed its discriminatory ability (AUC=0.80), identifying high Beclin-1 as a marker of reduced nCRT sensitivity. Lymphovascular invasion (LVI) and perineural invasion (PNI) were also associated with poor response ( P =0.002 each). In multivariate analysis, PNI showed borderline significance for nonresponse (OR=4.09, P =0.050). During follow-up, overall survival was adversely affected by LVI, PNI, higher T and N stage, and metastasis ( P P =0.026), while no marker correlated with disease-free survival. Beclin-1 overexpression may indicate therapy resistance through autophagy-related mechanisms, whereas eIF2α acts as a stress-response marker influencing survival. High Beclin-1 expression may serve as a predictive biomarker of poor nCRT response in rectal adenocarcinoma, while eIF2α shows prognostic significance for overall survival.
- 15 September 2026
- Published by Wolters Kluwer Health in Applied Immunohistochemistry & Molecular Morphology
- Vol. 34 (6) , 437-445
Autophagy- and Stress-Related Biomarkers in Pretreatment Rectal Adenocarcinoma Biopsies: Associations With Pathologic Response to Neoadjuvant Therapy and Survival
Neoadjuvant chemoradiotherapy (nCRT) is the standard treatment for locally advanced rectal adenocarcinoma, yet therapeutic response varies widely and reliable biomarkers are lacking. This study evaluated the immunohistochemical expression of Beclin-1, LC3A, HIF-1α, Bcl-2, and eIF2α in pretreatment biopsies and explored their association with tumor regression grade (TRG) and survival. A retrospective analysis was performed on 53 patients with rectal adenocarcinoma who underwent neoadjuvant therapy and surgical resection between 2010 and 2025. Immunohistochemical expression of 5 markers was evaluated semiquantitatively and correlated with TRG (both Modified Mandard and AJCC systems) and survival outcomes. Among the evaluated markers, only Beclin-1 expression correlated significantly with poorer histopathologic response in both TRG systems (Modified Mandard: ρ =0.35, P =0.010; AJCC: ρ =0.34, P =0.012). ROC analysis confirmed its discriminatory ability (AUC=0.80), identifying high Beclin-1 as a marker of reduced nCRT sensitivity. Lymphovascular invasion (LVI) and perineural invasion (PNI) were also associated with poor response ( P =0.002 each). In multivariate analysis, PNI showed borderline significance for nonresponse (OR=4.09, P =0.050). During follow-up, overall survival was adversely affected by LVI, PNI, higher T and N stage, and metastasis ( P P =0.026), while no marker correlated with disease-free survival. Beclin-1 overexpression may indicate therapy resistance through autophagy-related mechanisms, whereas eIF2α acts as a stress-response marker influencing survival. High Beclin-1 expression may serve as a predictive biomarker of poor nCRT response in rectal adenocarcinoma, while eIF2α shows prognostic significance for overall survival.
- Open Access
- 11 August 2026
- Published by Springer Nature in BMC Gastroenterology
- Vol. 26 (1) , 579
Histopathologic clues to mismatch repair deficiency in colon adenocarcinoma: the role of mucinous component and intratumoral/Crohn-like immune response
Deficient mismatch repair (dMMR) identifies a biologically distinct subset of colon adenocarcinomas with important diagnostic, hereditary, prognostic, and
- 11 August 2026
- Published by Springer Nature in BMC Gastroenterology
- Vol. 26 (1) , 579
Open AccessHistopathologic clues to mismatch repair deficiency in colon adenocarcinoma: the role of mucinous component and intratumoral/Crohn-like immune response
Deficient mismatch repair (dMMR) identifies a biologically distinct subset of colon adenocarcinomas with important diagnostic, hereditary, prognostic, and
- 9 June 2026
- Published by Osmangazi Journal of Medicine in OSMANGAZİ JOURNAL OF MEDICINE
- Vol. 48 (4) , 654-667
Non-gynecologic Ovarian Metastases: A Clinicopathologic and Immunophenotypic Study of 29 Cases
Metastatic tumors represent a substantial proportion of ovarian malignancies and may mimic primary ovarian neoplasms, posing significant diagnostic challenges. This study aimed to evaluate the clinicopathologic, morphologic, and immunohistochemical features of ovarian metastases from non-gynecologic primary tumors to facilitate identification of the primary tumor site. A retrospective analysis of 29 metastatic ovarian tumors diagnosed at a tertiary center was performed. Clinical data, tumor laterality, timing of metastasis, morphologic patterns, and immunohistochemical profiles were reviewed. Colorectal carcinoma was the most frequent primary tumor (41.4%), followed by gastric (20.7%), pancreaticobiliary (20.7%), and breast carcinomas (17.2%). Bilateral ovarian involvement and diffuse infiltrative growth with desmoplastic stroma were common findings. Colorectal metastases commonly exhibited tubuloglandular architecture with necrosis, whereas gastric tumors were characterized by signet-ring cell morphology. Immunohistochemical analysis revealed lineage-associated profiles: the CK7−/CK20+ pattern supported colorectal origin, whereas CK7+/CK20− favored breast carcinoma. The use of lineage-specific markers, including SATB2, ER/PR, and GATA3, improved diagnostic specificity. Integration of morphologic evaluation with CK7/CK20 immunophenotypic patterns and lineage-specific markers provides a practical framework for identifying the primary tumor in metastatic ovarian lesions.
- 9 June 2026
- Published by Osmangazi Journal of Medicine in OSMANGAZİ JOURNAL OF MEDICINE
- Vol. 48 (4) , 654-667
Non-gynecologic Ovarian Metastases: A Clinicopathologic and Immunophenotypic Study of 29 Cases
Metastatic tumors represent a substantial proportion of ovarian malignancies and may mimic primary ovarian neoplasms, posing significant diagnostic challenges. This study aimed to evaluate the clinicopathologic, morphologic, and immunohistochemical features of ovarian metastases from non-gynecologic primary tumors to facilitate identification of the primary tumor site. A retrospective analysis of 29 metastatic ovarian tumors diagnosed at a tertiary center was performed. Clinical data, tumor laterality, timing of metastasis, morphologic patterns, and immunohistochemical profiles were reviewed. Colorectal carcinoma was the most frequent primary tumor (41.4%), followed by gastric (20.7%), pancreaticobiliary (20.7%), and breast carcinomas (17.2%). Bilateral ovarian involvement and diffuse infiltrative growth with desmoplastic stroma were common findings. Colorectal metastases commonly exhibited tubuloglandular architecture with necrosis, whereas gastric tumors were characterized by signet-ring cell morphology. Immunohistochemical analysis revealed lineage-associated profiles: the CK7−/CK20+ pattern supported colorectal origin, whereas CK7+/CK20− favored breast carcinoma. The use of lineage-specific markers, including SATB2, ER/PR, and GATA3, improved diagnostic specificity. Integration of morphologic evaluation with CK7/CK20 immunophenotypic patterns and lineage-specific markers provides a practical framework for identifying the primary tumor in metastatic ovarian lesions.
- Open Access
- 15 May 2026
- Published by The Korean Society of Pathologists and The Korean Society for Cytopathology in Journal of Pathology and Translational Medicine
- Vol. 60 (3) , 349-355
Incidental serrated lesions of the appendix: analysis of 2,137 appendectomy specimens
Background: Serrated lesions of the appendix are rare, often incidental findings in routine appendectomy specimens. Their true frequency, histopathologic spectrum, and anatomic distribution remain incompletely characterized, partly due to variability in sampling practices. Methods: We retrospectively reviewed 2,137 appendectomy specimens (2015–2025) from a single tertiary pathology center. Cases with histologically confirmed serrated lesions were reexamined, classified as hyperplastic polyp (HP) or sessile serrated lesion/polyp (SSL/P), and assessed for clinicopathologic parameters including lesion size, location, and associated pathologies. Nonparametric tests were used, with statistical significance defined as p < .05. Results: Serrated lesions were identified in 34 cases (1.6%) with 36 serrated lesions, comprising 17 HPs (0.8%) and 19 SSL/Ps (0.9%). SSL/Ps were significantly larger than HPs (median 10.0 vs. 2.7 mm, p < .001) and were more frequently located in the distal appendix (68.4% vs. 33.3%, p = .045, one-tailed Fisher’s exact test). No dysplasia or traditional serrated adenoma was detected. Acute appendicitis was present in 88% of cases, and associated neoplasms in 9%. Conclusions: Appendiceal serrated lesions are uncommon and often incidental. In this large appendectomy series, SSL/Ps differed from HPs by larger size and distal predilection. These findings primarily support diagnostic awareness and optimized sampling/grossing practices—particularly careful evaluation of the distal appendix—rather than clinical risk stratification. Further studies incorporating systematic clinical correlation and molecular/immunohistochemistry analyses are warranted.
- 15 May 2026
- Published by The Korean Society of Pathologists and The Korean Society for Cytopathology in Journal of Pathology and Translational Medicine
- Vol. 60 (3) , 349-355
Open AccessIncidental serrated lesions of the appendix: analysis of 2,137 appendectomy specimens
Background: Serrated lesions of the appendix are rare, often incidental findings in routine appendectomy specimens. Their true frequency, histopathologic spectrum, and anatomic distribution remain incompletely characterized, partly due to variability in sampling practices. Methods: We retrospectively reviewed 2,137 appendectomy specimens (2015–2025) from a single tertiary pathology center. Cases with histologically confirmed serrated lesions were reexamined, classified as hyperplastic polyp (HP) or sessile serrated lesion/polyp (SSL/P), and assessed for clinicopathologic parameters including lesion size, location, and associated pathologies. Nonparametric tests were used, with statistical significance defined as p < .05. Results: Serrated lesions were identified in 34 cases (1.6%) with 36 serrated lesions, comprising 17 HPs (0.8%) and 19 SSL/Ps (0.9%). SSL/Ps were significantly larger than HPs (median 10.0 vs. 2.7 mm, p < .001) and were more frequently located in the distal appendix (68.4% vs. 33.3%, p = .045, one-tailed Fisher’s exact test). No dysplasia or traditional serrated adenoma was detected. Acute appendicitis was present in 88% of cases, and associated neoplasms in 9%. Conclusions: Appendiceal serrated lesions are uncommon and often incidental. In this large appendectomy series, SSL/Ps differed from HPs by larger size and distal predilection. These findings primarily support diagnostic awareness and optimized sampling/grossing practices—particularly careful evaluation of the distal appendix—rather than clinical risk stratification. Further studies incorporating systematic clinical correlation and molecular/immunohistochemistry analyses are warranted.
- Open Access
- 14 April 2026
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 56 (2) , 541-553
Prognostic significance and clinicopathological associations of tumor budding and poorly differentiated clusters in endometrioid endometrial carcinoma
Background/aim: Tumor budding (TB) and poorly differentiated clusters (PDCs) are histopathological parameters that have been associated with poor prognosis in various malignancies, particularly colorectal carcinoma. Although numerous studies have demonstrated an association between the microcystic, elongated, and fragmented (MELF) pattern in endometrial carcinomas and lymphovascular invasion as well as lymph node metastasis, the literature regarding TB and PDCs in this context remains limited. This study aimed to investigate the potential associations of the MELF pattern, TB, and PDCs with overall survival, progression-free survival, and clinicopathological parameters in cases of endometrioid endometrial carcinoma (EEC). Materials and methods: A total of 190 cases diagnosed with EEC through hysterectomy specimens between 2010 and 2023, with complete hospital records, were selected from the archives of the Department of Pathology at Manisa Celal Bayar University Faculty of Medicine. Results: The presence of TB and PDCs was significantly associated with high histological grade (p < 0.001), deep myometrial invasion (p < 0.001), lymphovascular invasion (p < 0.001), lymph node metastasis (p < 0.001), cervical stromal involvement (p < 0.001), serosal involvement (p < 0.001), advanced stage (p < 0.001), and larger tumor size (p = 0.042 and p = 0.027, respectively). The presence of TB and PDCs was found to be associated with reduced overall survival (p = 0.001 and p < 0.001, respectively) and reduced progression-free survival (p = 0.043 and p = 0.004, respectively). The MELF pattern was not significantly associated with overall survival (p = 0.772). Conclusion: These findings suggest that the presence of TB and PDCs may be valuable in stratifying prognostic risk in EEC and support the inclusion of these parameters in routine pathology reporting.
- 14 April 2026
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 56 (2) , 541-553
Open AccessPrognostic significance and clinicopathological associations of tumor budding and poorly differentiated clusters in endometrioid endometrial carcinoma
Background/aim: Tumor budding (TB) and poorly differentiated clusters (PDCs) are histopathological parameters that have been associated with poor prognosis in various malignancies, particularly colorectal carcinoma. Although numerous studies have demonstrated an association between the microcystic, elongated, and fragmented (MELF) pattern in endometrial carcinomas and lymphovascular invasion as well as lymph node metastasis, the literature regarding TB and PDCs in this context remains limited. This study aimed to investigate the potential associations of the MELF pattern, TB, and PDCs with overall survival, progression-free survival, and clinicopathological parameters in cases of endometrioid endometrial carcinoma (EEC). Materials and methods: A total of 190 cases diagnosed with EEC through hysterectomy specimens between 2010 and 2023, with complete hospital records, were selected from the archives of the Department of Pathology at Manisa Celal Bayar University Faculty of Medicine. Results: The presence of TB and PDCs was significantly associated with high histological grade (p < 0.001), deep myometrial invasion (p < 0.001), lymphovascular invasion (p < 0.001), lymph node metastasis (p < 0.001), cervical stromal involvement (p < 0.001), serosal involvement (p < 0.001), advanced stage (p < 0.001), and larger tumor size (p = 0.042 and p = 0.027, respectively). The presence of TB and PDCs was found to be associated with reduced overall survival (p = 0.001 and p < 0.001, respectively) and reduced progression-free survival (p = 0.043 and p = 0.004, respectively). The MELF pattern was not significantly associated with overall survival (p = 0.772). Conclusion: These findings suggest that the presence of TB and PDCs may be valuable in stratifying prognostic risk in EEC and support the inclusion of these parameters in routine pathology reporting.
- Open Access
- 25 February 2026
- Published by Turkish Journal of Public Health in Türkiye Halk Sağlığı Dergisi
- Vol. 24 (1)
A 10-year analysis of Helicobacter pylori positivity in gastric biopsies: Impact of seasonality and the COVID-19 pandemic-a single-center experience.
Objective: This study aimed to investigate the annual, seasonal, and monthly trends in Helicobacter pylori (HP) positivity over ten years and to assess the potential impact of the COVID-19 pandemic on diagnostic patterns.Method: A retrospective analysis was conducted on 17,091 gastric biopsies performed between 2015 and 2024. HP infection was diagnosed histologically using toluidine blue staining. The data were classified by month, season, and year, and comparisons were made across the pre-pandemic (2015-2019), pandemic (2020-2021), and post-pandemic (2022-2024) periods.Results: The overall HP positivity rate was 29.1%. Positivity was significantly higher in males (30.3%) than in females (28.2%) (p=0.002), although the effect size was minimal. Younger individuals had a significantly higher HP positivity rate (mean age: 49.0 vs. 54.1 years, p<0.001). HP positivity showed minor monthly variation, with the highest rate in August (33.3%) and the lowest in February (27.3%) (p=0.044; minimal effect size). No significant differences were observed in seasonal positivity rates. HP positivity decreased during the pandemic years (26.4%) and showed a significant upward trend post-pandemic, reaching 32.0% in 2024 (p=0.002). However, the pandemic's overall effect on HP positivity rates was limited.Conclusion: Although minor seasonal and monthly fluctuations were detected, they were not clinically meaningful. The pandemic temporarily reduced HP detection rates, likely due to restricted access to healthcare services. Post-pandemic increases in positivity may reflect delayed diagnoses and rising antibiotic resistance. Continued monitoring of HP trends is essential for guiding public health strategies.
- 25 February 2026
- Published by Turkish Journal of Public Health in Türkiye Halk Sağlığı Dergisi
- Vol. 24 (1)
Open AccessA 10-year analysis of Helicobacter pylori positivity in gastric biopsies: Impact of seasonality and the COVID-19 pandemic-a single-center experience.
Objective: This study aimed to investigate the annual, seasonal, and monthly trends in Helicobacter pylori (HP) positivity over ten years and to assess the potential impact of the COVID-19 pandemic on diagnostic patterns.Method: A retrospective analysis was conducted on 17,091 gastric biopsies performed between 2015 and 2024. HP infection was diagnosed histologically using toluidine blue staining. The data were classified by month, season, and year, and comparisons were made across the pre-pandemic (2015-2019), pandemic (2020-2021), and post-pandemic (2022-2024) periods.Results: The overall HP positivity rate was 29.1%. Positivity was significantly higher in males (30.3%) than in females (28.2%) (p=0.002), although the effect size was minimal. Younger individuals had a significantly higher HP positivity rate (mean age: 49.0 vs. 54.1 years, p<0.001). HP positivity showed minor monthly variation, with the highest rate in August (33.3%) and the lowest in February (27.3%) (p=0.044; minimal effect size). No significant differences were observed in seasonal positivity rates. HP positivity decreased during the pandemic years (26.4%) and showed a significant upward trend post-pandemic, reaching 32.0% in 2024 (p=0.002). However, the pandemic's overall effect on HP positivity rates was limited.Conclusion: Although minor seasonal and monthly fluctuations were detected, they were not clinically meaningful. The pandemic temporarily reduced HP detection rates, likely due to restricted access to healthcare services. Post-pandemic increases in positivity may reflect delayed diagnoses and rising antibiotic resistance. Continued monitoring of HP trends is essential for guiding public health strategies.
- Open Access
- 31 January 2026
- Published by Tıp Fakültesi, Karadeniz Teknik Üniversitesi in Farabi Tıp Dergisi
- Vol. 5 (1) , 1-23
Clinicopathologic Significance of Tumor Deposits in Colon Adenocarcinoma: Associations with Regional Tumor Burden and Adverse Invasive Features
Objective: To evaluate whether tumor deposit presence was associated with histologically confirmed regional lymph node metastasis in colon adenocarcinoma. Associations with other clinicopathologic features, tumor deposit count, and overall survival were evaluated as secondary or exploratory objectives. Material and Methods: This retrospective cohort study included 191 patients who underwent colon resection for adenocarcinoma. Rectal tumors, neoadjuvant-treated cases, and non-resection specimens were excluded. Tumor deposit data were extracted from the original pathology reports, in which deposits had been classified according to College of American Pathologists criteria, and were analyzed by presence and count (0, 1, or ≥2). Histologically confirmed lymph node metastasis was defined as the primary outcome. Associations with other clinicopathologic features were considered secondary, whereas tumor deposit count-based, subgroup, alternative nodal classification, and overall survival analyses were considered exploratory. Results: Tumor deposits were identified in 35 of 191 patients (18.3%). Compared with tumor deposit-negative cases, tumor deposit-positive tumors more often showed histologically confirmed lymph node metastasis, extramural venous invasion, lymphovascular invasion, perineural invasion, serosal involvement, and advanced pathological T stage. Exploratory count-based analyses showed associations with metastatic lymph node burden and PNI after FDR correction. The weak overall correlation with tumor budding count did not persist when the analysis was restricted to tumor deposit-positive patients. In the exploratory node-positive subgroup, no association remained significant after FDR correction. Tumor deposits were associated with shorter overall survival in univariable analysis; however, an independent association could not be demonstrated after adjustment for the selected clinical and pathological factors. Conclusion: Tumor deposits in colon adenocarcinoma were associated with histologically confirmed lymph node metastasis and several adverse invasive features. None of the examined associations met the FDR-adjusted significance threshold in the exploratory node-positive subgroup. Although tumor deposit status was associated with shorter overall survival in univariable analysis, an independent association could not be demonstrated after adjustment for the selected factors. The limited number of deaths and relatively short follow-up preclude excluding a clinically relevant independent effect.
- 31 January 2026
- Published by Tıp Fakültesi, Karadeniz Teknik Üniversitesi in Farabi Tıp Dergisi
- Vol. 5 (1) , 1-23
Open AccessClinicopathologic Significance of Tumor Deposits in Colon Adenocarcinoma: Associations with Regional Tumor Burden and Adverse Invasive Features
Objective: To evaluate whether tumor deposit presence was associated with histologically confirmed regional lymph node metastasis in colon adenocarcinoma. Associations with other clinicopathologic features, tumor deposit count, and overall survival were evaluated as secondary or exploratory objectives. Material and Methods: This retrospective cohort study included 191 patients who underwent colon resection for adenocarcinoma. Rectal tumors, neoadjuvant-treated cases, and non-resection specimens were excluded. Tumor deposit data were extracted from the original pathology reports, in which deposits had been classified according to College of American Pathologists criteria, and were analyzed by presence and count (0, 1, or ≥2). Histologically confirmed lymph node metastasis was defined as the primary outcome. Associations with other clinicopathologic features were considered secondary, whereas tumor deposit count-based, subgroup, alternative nodal classification, and overall survival analyses were considered exploratory. Results: Tumor deposits were identified in 35 of 191 patients (18.3%). Compared with tumor deposit-negative cases, tumor deposit-positive tumors more often showed histologically confirmed lymph node metastasis, extramural venous invasion, lymphovascular invasion, perineural invasion, serosal involvement, and advanced pathological T stage. Exploratory count-based analyses showed associations with metastatic lymph node burden and PNI after FDR correction. The weak overall correlation with tumor budding count did not persist when the analysis was restricted to tumor deposit-positive patients. In the exploratory node-positive subgroup, no association remained significant after FDR correction. Tumor deposits were associated with shorter overall survival in univariable analysis; however, an independent association could not be demonstrated after adjustment for the selected clinical and pathological factors. Conclusion: Tumor deposits in colon adenocarcinoma were associated with histologically confirmed lymph node metastasis and several adverse invasive features. None of the examined associations met the FDR-adjusted significance threshold in the exploratory node-positive subgroup. Although tumor deposit status was associated with shorter overall survival in univariable analysis, an independent association could not be demonstrated after adjustment for the selected factors. The limited number of deaths and relatively short follow-up preclude excluding a clinically relevant independent effect.
- 1 October 2025
- Published by Pamukkale University in Pamukkale Medical Journal
- No. Advanced O,p. 5
Evaluation of the concordance of ER, PR, HER2, and Ki-67 expression levels between primary breast tumors and their liver metastases: a retrospective analysis of 57 cases
Purpose: This study aims to evaluate the changes in estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and Ki-67 expression between primary breast tumors and their liver metastases. Materials and methods: A total of 57 patients with breast cancer liver metastases were included. Immunohistochemical staining was performed to assess ER, PR, HER2, and Ki-67 expression in both primary and metastatic tumors. HER2 status was confirmed by silver in situ hybridization (SISH) when necessary. Statistical analyses were conducted to evaluate changes in biomarker expression. Results: Comparison of biomarker expression between primary and metastatic biopsies revealed changes in ER status in 5 cases (1 from negative to positive, 4 from positive to negative); PR status in 22 cases (4 from negative to positive, 18 from positive to negative); HER2 status in 5 cases (2 from negative to positive, 3 from positive to negative); and Ki-67 status in 13 cases (6 from low to high, 7 from high to low). The discordance rates for ER, PR, HER2, and Ki-67 were calculated as 8.8%, 38.6%, 8.8%, and 28.9%, respectively. Conclusion: Our findings confirm that biomarker expression may change between primary and metastatic breast cancer lesions. Given the crucial role of receptor status in treatment decisions, re-biopsy of metastatic lesions is essential to guide personalized therapy.
- 1 October 2025
- Published by Pamukkale University in Pamukkale Medical Journal
- No. Advanced O,p. 5
Evaluation of the concordance of ER, PR, HER2, and Ki-67 expression levels between primary breast tumors and their liver metastases: a retrospective analysis of 57 cases
Purpose: This study aims to evaluate the changes in estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and Ki-67 expression between primary breast tumors and their liver metastases. Materials and methods: A total of 57 patients with breast cancer liver metastases were included. Immunohistochemical staining was performed to assess ER, PR, HER2, and Ki-67 expression in both primary and metastatic tumors. HER2 status was confirmed by silver in situ hybridization (SISH) when necessary. Statistical analyses were conducted to evaluate changes in biomarker expression. Results: Comparison of biomarker expression between primary and metastatic biopsies revealed changes in ER status in 5 cases (1 from negative to positive, 4 from positive to negative); PR status in 22 cases (4 from negative to positive, 18 from positive to negative); HER2 status in 5 cases (2 from negative to positive, 3 from positive to negative); and Ki-67 status in 13 cases (6 from low to high, 7 from high to low). The discordance rates for ER, PR, HER2, and Ki-67 were calculated as 8.8%, 38.6%, 8.8%, and 28.9%, respectively. Conclusion: Our findings confirm that biomarker expression may change between primary and metastatic breast cancer lesions. Given the crucial role of receptor status in treatment decisions, re-biopsy of metastatic lesions is essential to guide personalized therapy.